This week, host Eve Young, economics correspondent for The Jerusalem Post, interviews Noam Solomon - CEO and co-founder at Immunai.
Immunai is a biotechnology company working to comprehensively map and decode the immune system with single-cell biology and AI to make new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Noam will talk about how Immunai uses AI and machine learning to make medical advancements, and explain what machine learning is in laymans terms. He will also explain what kind of team is best suited to face the challenges of a complex, deep science problem like mapping human immunity.
Israeli Innovation is your go-to podcast for all things to do with innovation in Israel. Join Eve Young as she delves into the heart of Israel's tech and business scenes and uncovers the groundbreaking ideas and visionary minds working to shape the future. Join her each week as she shines a spotlight on the latest trends and entrepreneurial spirit propelling Israel to the forefront of global innovation.
Listen here, on Apple, Spotify, or wherever you get your podcasts.